Hints and tips:
...’s Astellas Pharma on espionage charges....
...Nippon Steel snapped up US Steel for $14.9bn last month. Astellas Pharma bought eye-treatment specialist Iveric Bio in a $5.9bn deal in May....
...Astellas Pharma has agreed to buy US biotech group Iveric Bio for roughly $5.9bn, marking the Japanese drugmaker’s largest-ever acquisition and giving it access to the rapidly expanding market for age-related...
...Tokyo has argued that the measure was not targeted at China, but Beijing views it as in alignment with US steps to cut off China’s access to tools needed to manufacture advanced chips....
...Pharma; levied a record fine against Deloitte, and amended its espionage law to cover ordinary business activities....
...The European Medicines Agency has accelerated the approval process for a Covid-19 vaccine developed by Germany’s BioNTech and US pharma group Pfizer, to allow for the rapid authorisation of the shot as soon...
...Around that time, rival KKR also declared the country its “highest priority” market outside the US....
...We can move faster than pharma.” Hope for sickle cell Victoria Gray had been ill for all of her 34 years....
...From our perspective the strategic rationale of the deal would be limited: GILD’s is currently a similarly sized pharma business to AZN (2020E $25bn on our US colleague’s estimates vs. $26bn on ours for...
...Germany's telecoms regulator says Huawei can stay in the 5G network race, the European Central Bank faces stimulus pressure over a falling inflation outlook and the FT reports that Purdue Pharma, the makers...
...Pfizer generated $141m from sales of Xtandi in the US, which are shared with Japanese pharmaceutical group Astellas under a corporate alliance....
...In 2010, Astellas Pharma went public with a $52 a share offer for OSI Pharmaceuticals and then nominated new directors. The two sides agreed a $57.50 offer....
...Thanks to a series of court rulings since the mid-2000s, such as eBay v MercExchange in 2007, Mayo Collaborative Services v Prometheus Laboratories in 2012 and Alice Corp v CLS Bank in 2014, and the subsequent...
...Pfizer recorded $141m of revenues from the medicine, which is sold under a revenue-sharing agreement with Japanese drugmaker Astellas Pharma — around a fifth lower than the $169m that Wall Street analysts...
...The group posted net income of $240m for the three months to June 30, compared with a $162m loss a year earlier because of costs related to its purchase of US biotech Baxalta last year....
...Japanese prescription drug maker Astellas Pharma, a company that derives a third of its revenue from North America, according to Bloomberg data, tumbled 3.9 per cent....
...Asian pharma groups were also under the cosh as they played catch-up to sector falls in the US and Europe....
...In Japan, Takeda Pharmaceutical slid 2.7 per cent, Astellas Pharma fell 3.9 per cent and Shionogi sank 3.7 per cent on Thursday morning, while in Australia biotech company CSL Ltd dropped 1.4 per cent and...
...Total revenues for Xtandi were already forecast to rise from $2.2bn in the last four quarters to over $5bn in 2020 (these are shared equally with Astellas Pharma)....
...Half of US revenues go to Astellas, the Japanese drugmaker that agreed to co-develop Xtandi with Medivation in 2009, and which has exclusive rights to the medicine elsewhere in the world....
...Astellas to have a higher market cap.”...
...Among them, companies as diverse as Astellas Pharma, Shin-Etsu Chemical and Toyota benefit....
...That saw the creation of Astellas Pharma, formed from a merger between Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical in 2005. Sankyo agreed to buy Daiichi Pharmaceutical the same year....
...(FT) Journalism v Silicon Valley The media has lost control of production and distribution to the opaque algorithms of Google and Facebook....
...He splits his time between three cities: London, where he works as chief strategy officer at Astellas Pharma Inc; Tokyo, which he considers home; and Chicago, where his wife, Miwa, 47, who also works for...
International Edition